Australian public assessment report for Rituximab

This application is a hybrid submission requesting an extension of indication for rituximab (RTX) to include the induction of remission in patients with severely active granulomatosis with polyangiitis (GPA, previously known as Wegener’s granulomatosis) and microscopic polyangiitis (MPA) in combination with corticosteroids (CS). ................
................